UPDATE ON LABORATORY PARAMETERS RELATED TO MONITORING IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH TOFACITINIB IN THE OCTAVE OPEN-LABEL, LONG-TERM EXTENSION STUDY

Gil Y. Melmed  1     Shannon Chang  2     nicole kulisek  3     Kenneth Kwok  4     Nervin Lawendy  4     Peter Irving  5    
1 Cedars-Sinai Medical Center, Los Angeles, United States
2 New York University, Langone Health, New York, United States
3 Pfizer Inc, Collegeville, United States
4 Pfizer Inc, New York, United States
5 Guy’s and St Thomas’ Hospital, London, United Kingdom

Session
IBD (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing